Heart Test Company Cardiox Closes $8 Million Series C Round  
9/1/2011 7:49:01 AM

Heart test-maker CardiOx has closed an $8 million series C round of investment that the company plans to use to begin U.S. and European commercialization. The round was led by Michigan-based Lifeline Ventures, a new investor in Columbus, Ohio-based CardiOx, and included contributions from existing investors Early Stage Partners, Glengary and Reservoir Partners, CardiOx CEO Larry Heaton said. CardiOx plans to file by the end of the year for both U.S. and European regulatory clearance of its heart test, Heaton said.